NEW DATA FROM HEARTMATE II PHASE I TRIAL RELEASED AT AMERICAN HEART ASSOCIATION 2005 SCIENTIFIC SESSIONS

Thoratec, a world leader in products to treat cardiovascular disease, recently said that the first major presentation of data from the Phase I trial for its HeartMate II LVAS (left ventricular assist system) demonstrates encouraging results in terms of both patient survival and quality of life.

PR Newswire (http://www.prnewswire.com/news/index_mail.shtml?ACCT=104&STORY=/www/story/11-14-2005/0004215406&EDATE=)